Design, synthesis and structure-activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)

被引:8
|
作者
Wang, Xueying [1 ]
Xue, Gang [1 ]
Pan, Zhengying [1 ]
机构
[1] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, State Key Lab Chem Oncogen,Engn Lab Chiral Drug S, Shenzhen 518055, Peoples R China
基金
中国国家自然科学基金;
关键词
ITK; Tyrosine kinase; Covalent inhibitor; T-cell receptor; Indolylindazole; IRREVERSIBLE INHIBITORS; TEC KINASES; DISCOVERY; FAMILY; SAR; RLK;
D O I
10.1016/j.ejmech.2019.111918
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Interleukin-2 inducible T-cell kinase (ITK), a member of the Tec family of tyrosine kinases, plays an important role in T cell signaling downstream of the T-cell receptor (TCR). Herein we report the discovery of a series of indolylindazole based covalent ITK inhibitors with nanomolar inhibitory potency against ITK, good kinase selectivity and potent inhibition of the phosphorylation of PLC gamma l and ERK1/2 in living cells. A computational study provided insight into the interactions between inhibitors and Phe437 at the ATP binding pocket of ITK, suggesting that both edge-to-face pi-pi interaction and the dihedral torsion angle contribute to inhibitors' potency. Compounds 43 and 55 stood out as selective covalent inhibitors with potent cellular activity, which could be used as chemical tools for further study of ITK functions. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Discovery of ARN-4079-a Potent, Orally Available Dual Target Inhibitor of Janus Kinase 3 (JAK3) and Interleukin-2 Inducible T-Cell Kinase (ITK) for Rheumatoid Arthritis.
    Vankayalapati, Hariprasad
    Yerramreddy, Venkatakrishnareddy
    Bendele, Philip
    Bendele, Alison
    Issac, Rueban Jacob Anicattu
    Adluri, Ram Sudheer
    LoGrasso, Philip
    Kremer, Joel M.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S652 - S652
  • [42] Design, synthesis, and structure-activity relationship of pyridyl imidazolidinones: A novel class of potent and selective human enterovirus 71 inhibitors
    Shia, KS
    Li, WT
    Chang, CM
    Hsu, MC
    Chern, JH
    Leong, MK
    Tseng, SN
    Lee, CC
    Lee, YC
    Chen, SJ
    Peng, KC
    Tseng, HY
    Chang, YL
    Tai, CL
    Shih, SR
    JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (08) : 1644 - 1655
  • [43] Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma
    Youssefian, Leila
    Vahidnezhad, Hassan
    Yousefi, Mehdi
    Saeidian, Amir Hossein
    Azizpour, Arghavan
    Touati, Andrew
    Nikbakht, Neda
    Kamyab-Hesari, Kambiz
    Adib-Sereshki, Mohammad Mahdi
    Zeinali, Sirous
    Mansoori, Behzad
    Jazayeri, Ali
    Karamzadeh, Razieh
    Fortina, Paolo
    Jouanguy, Emmanuelle
    Casanova, Jean-Laurent
    Uitto, Jouni
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (11) : 1938 - 1941
  • [44] Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT
    Mammadli, Mahinbanu
    Huang, Weishan
    Harris, Rebecca
    Sultana, Aisha
    Cheng, Ying
    Tong, Wei
    Pu, Jeffery
    Gentile, Teresa
    Dsouza, Shanti
    Yang, Qi
    Bah, Alaji
    August, Avery
    Karimi, Mobin
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [45] Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches
    Chandrasekaran Meganathan
    Sugunadevi Sakkiah
    Yuno Lee
    Jayavelu Venkat Narayanan
    Keun Woo Lee
    Journal of Molecular Modeling, 2013, 19 : 715 - 726
  • [46] Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches
    Meganathan, Chandrasekaran
    Sakkiah, Sugunadevi
    Lee, Yuno
    Narayanan, Jayavelu Venkat
    Lee, Keun Woo
    JOURNAL OF MOLECULAR MODELING, 2013, 19 (02) : 715 - 726
  • [47] Complex role for Interleukin-2 inducible T-cell kinase in T helper differentiation and effector function in vivo
    Kannan, Arun
    Butcher, Barbara
    Kim, Do-Geun
    Lee, Yong
    Bynoe, Margaret
    Denkers, Eric
    August, Avery
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [48] Design, synthesis and structure-activity relationship study of aminopyridine derivatives as novel inhibitors of Janus kinase 2
    Wang, Wanqi
    Diao, Yanyan
    Li, Wenjie
    Luo, Yating
    Yang, Tingyuan
    Zhao, Yuyu
    Qi, TianTian
    Xu, Fangling
    Ma, Xiangyu
    Ge, Huan
    Liang, Yingfan
    Zhao, Zhenjiang
    Liang, Xin
    Wang, Rui
    Zhu, Lili
    Li, Honglin
    Xu, Yufang
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (12) : 1507 - 1513
  • [49] A negative role for the interleukin-2-inducible T-cell kinase (ITK) in human Foxp3+ TREG differentiation
    Mamontov, Polina
    Eberwine, Ryan A.
    Perrigoue, Jackie
    Das, Anuk
    Friedman, Joshua R.
    Mora, J. Rodrigo
    PLOS ONE, 2019, 14 (04):
  • [50] Discovery and structure-activity relationship of 2,6-disubstituted pyrazines, potent and selective inhibitors of protein kinase CK2
    Fuchi, Nobuhiro
    Iura, Yosuke
    Kaneko, Hiroaki
    Nitta, Aiko
    Suyama, Kazuharu
    Ueda, Hiroshi
    Yamaguchi, Shinichi
    Nishimura, Kazumi
    Fujii, Shigeo
    Sekiya, Yumiko
    Yamada, Masateru
    Takahashi, Toshiya
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (13) : 4358 - 4361